3 Results for "

BL-B01D1

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "BL-B01D1" in MCE Product Catalog:

Cat. No.: HY-164702
Synonyms: Izalontamab Brengitecan
Research Areas:  

Cancer

BL-B01D1 (Izalontamab Brengitecan) is a bispecific antibody-drug conjugate (ADC) targeting EGFR and HER3, formed by conjugating the EGFR/HER3 bispecific antibody Izalontamab (HY-P99676) to a novel TOP-I inhibitor payload Deruxtecan 2-hydroxypropanamide (HY-153891) via a cleavable linker (Mc-Gly-Gly-Phe-Gly). BL-B01D1 binds to EGFR and HER3 on the surface of tumor cells, mediates endocytosis and releases the payload, inhibits topoisomerase I, blocks DNA replication and RNA synthesis, and disrupts DNA structure. BL-B01D1 induces cell cycle S-phase arrest, apoptosis, antibody-dependent cell-mediated cytotoxicity, and tumor cell death. BL-B01D1 can be used for cancer research .
loading...
    loading...
Cat. No.: HY-P99676
CAS No.: 2559704-24-2
Synonyms: SI-B001; BL-B01D1 Antibody

Target:  

EGFR

Research Areas:  

Cancer

Izalontamab (SI-B001) is a bispecific anti-EGFR/HER3 monoclonal antibody with high selectivity for EGFR/HER3 heterodimer. Izalontamab can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-185294
Research Areas:  

Others

ADC Control human IgG1-ED04 is an ADC control composed of Human IgG1 kappa, Isotype Control (HY-P99001) and ADC toxin ED04 (HY-153891). It can be used as an isotype control for BL-B01D1 (HY-164702).
loading...
    loading...